Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials.
Cassese S, Kufner S, Xhepa E, Byrne RA, Kreutzer J, Ibrahim T, Tiroch K, Valgimigli M, Tölg R, Fusaro M, Schunkert H, Laugwitz KL, Mehilli J, Kastrati A. Cassese S, et al. Among authors: tolg r. Clin Res Cardiol. 2016 Jul;105(7):575-84. doi: 10.1007/s00392-015-0953-x. Epub 2015 Dec 22. Clin Res Cardiol. 2016. PMID: 26689707 Free article. Clinical Trial.
Carvedilol versus metoprolol in the acute phase of myocardial infarction:
Bonnemeier H, Ortak J, Tölg R, Witt M, Schmidt J, Wiegand UK, Bode F, Schunkert H, Richardt G. Bonnemeier H, et al. Among authors: tolg r. Pacing Clin Electrophysiol. 2005 Jan;28 Suppl 1:S222-6. doi: 10.1111/j.1540-8159.2005.00014.x. Pacing Clin Electrophysiol. 2005. PMID: 15683501 Clinical Trial.
No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry.
Akin I, Tölg R, Hochadel M, Bergmann MW, Khattab AA, Schneider S, Senges J, Kuck KH, Richardt G, Nienaber CA; DES.DE (German Drug-Eluting Stent) Study Group. Akin I, et al. Among authors: tolg r. JACC Cardiovasc Interv. 2012 Feb;5(2):162-9. doi: 10.1016/j.jcin.2011.09.021. JACC Cardiovasc Interv. 2012. PMID: 22361600 Free article.
Outcome of percutaneous coronary intervention with drug-eluting stents in unprotected left main versus non-left main native coronary artery disease: results from the prospective multicenter German DES.DE registry.
Akin I, Naber C, Sabin G, Hochadel M, Senges J, Kuck KH, Nienaber C, Richardt G, Tölg R. Akin I, et al. Among authors: tolg r. Clin Res Cardiol. 2013 Sep;102(9):679-86. doi: 10.1007/s00392-013-0582-1. Epub 2013 May 17. Clin Res Cardiol. 2013. PMID: 23681360
79 results